1. Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses? Authors' reply. Issue 8 (25th March 2018) Authors: Bettinger, D.; Thimme, R.; Boettler, T. Journal: Alimentary pharmacology & therapeutics Issue: Volume 47:Issue 8(2018) Page Start: 1228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma – authors' reply. Issue 2 (January 2015) Authors: Bettinger, D.; Knüppel, E.; Euringer, W.; Spangenberg, H. C.; Rössle, M.; Thimme, R.; Schultheiß, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 2(2015) Page Start: 231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Issue 1 (20th October 2014) Authors: Bettinger, D.; Knüppel, E.; Euringer, W.; Spangenberg, H. C.; Rössle, M.; Thimme, R.; Schultheiß, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 1(2015) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016. (May 2017) Authors: Pichler, C.; Büchsel, M.; Rossen, J.W.; Vavra, M.; Reuter, S.; Kern, W.V.; Thimme, R.; Mischnik, A. Journal: New microbes and new infections Issue: Volume 17(2017) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study. Issue 8 (2nd March 2017) Authors: Howell, J.; Pinato, D. J.; Ramaswami, R.; Bettinger, D.; Arizumi, T.; Ferrari, C.; Yen, C.; Gibbin, A.; Burlone, M. E.; Guaschino, G.; Sellers, L.; Black, J.; Pirisi, M.; Kudo, M.; Thimme, R.; Park, J.‐W.; Sharma, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 8(2017) Page Start: 1146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study. Issue 8 (2nd March 2017) Authors: Howell, J.; Pinato, D. J.; Ramaswami, R.; Bettinger, D.; Arizumi, T.; Ferrari, C.; Yen, C.; Gibbin, A.; Burlone, M. E.; Guaschino, G.; Sellers, L.; Black, J.; Pirisi, M.; Kudo, M.; Thimme, R.; Park, J.‐W.; Sharma, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 8(2017) Page Start: 1146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PO-0767: Local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis. (April 2018) Authors: Gkika, E.; Bettinger, D.; Schultheiss, M.; Glaser, N.; Lange, S.; Maruschke, L.; Buettner, N.; Kirste, S.; Nestle, U.; Grosu, A.L.; Thimme, R.; Brunner, T. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis. (April 2019) Authors: Gkika, E.; Brunner, T.; Abbasi-Senger, N.; Alheit, H.; Baus, W.; Blanck, O.; Gerum, S.; Guckenberger, M.; Habermehl, D.; Ostheimer, C.; Riesterer, O.; Tamihardja, J.; Pinato, D.J.; Rimassa, L.; Pressiani, T.; Schultheiss, M.; Sharma, R.; Burlone, M.E.; Pirisi, M.; Kudo, M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-1050: SBRT in liver cancer versus TACE. A prospective, non-randomised observational trial (HERACLES). (November 2020) Authors: Brunner, T.; Gkika, E.; Bettinger, D.; Schultheiss, M.; Maruschke, L.; Bartl, N.; Kirste, S.; Bamberg, F.; Thimme, R.; Grosu, A. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Procedural and shunt‐related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Issue 10 (27th September 2016) Authors: Bettinger, D.; Schultheiss, M.; Boettler, T.; Muljono, M.; Thimme, R.; Rössle, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 10(2016) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗